646 related articles for article (PubMed ID: 18567695)
1. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
3. Effect of renin-angiotensin system inhibitors on prevention of peritoneal fibrosis in peritoneal dialysis patients.
Jing S; Kezhou Y; Hong Z; Qun W; Rong W
Nephrology (Carlton); 2010 Feb; 15(1):27-32. PubMed ID: 20377768
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
[TBL] [Abstract][Full Text] [Related]
6. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre.
Fang W; Qian J; Lin A; Rowaie F; Ni Z; Yao Q; Bargman JM; Oreopoulos DG
Nephrol Dial Transplant; 2008 Dec; 23(12):4021-8. PubMed ID: 18790809
[TBL] [Abstract][Full Text] [Related]
7. Therapy outcome in peritoneal dialysis patients transferred from haemodialysis.
Liberek T; Renke M; Skonieczny B; Kotewicz K; Kowalewska J; Chmielewski M; Kot J; Lichodziejewska-Niemierko M; Rutkowski B
Nephrol Dial Transplant; 2009 Sep; 24(9):2889-94. PubMed ID: 19342418
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
9. Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised?
Covic A; Mardare N; Gusbeth-Tatomir P; Prisada O; Sascau R; Goldsmith DJ
Nephrol Dial Transplant; 2006 Oct; 21(10):2859-66. PubMed ID: 16854850
[TBL] [Abstract][Full Text] [Related]
10. Study of ACEI versus ARB in managing hypertensive overt diabetic nephropathy: long-term analysis.
Ozturk S; Sar F; Bengi-Bozkurt O; Kazancioglu R
Kidney Blood Press Res; 2009; 32(4):268-75. PubMed ID: 19776644
[TBL] [Abstract][Full Text] [Related]
11. Pulse pressure and inhibition of renin-angiotensin system in chronic kidney disease.
Banerjee D; Brincat S; Gregson H; Contreras G; Streather C; Oliveira D; Nelson S
Nephrol Dial Transplant; 2006 Apr; 21(4):975-8. PubMed ID: 16384830
[TBL] [Abstract][Full Text] [Related]
12. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
Ferrari P
Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
[TBL] [Abstract][Full Text] [Related]
13. High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis.
Wiggins KJ; McDonald SP; Brown FG; Rosman JB; Johnson DW
Nephrol Dial Transplant; 2007 Oct; 22(10):3005-12. PubMed ID: 17545674
[TBL] [Abstract][Full Text] [Related]
14. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.
Johnson DW; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Badve SV
Nephrol Dial Transplant; 2010 Jun; 25(6):1973-9. PubMed ID: 20097847
[TBL] [Abstract][Full Text] [Related]
15. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
16. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
17. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis.
Liao CT; Chen YM; Shiao CC; Hu FC; Huang JW; Kao TW; Chuang HF; Hung KY; Wu KD; Tsai TJ
Nephrol Dial Transplant; 2009 Sep; 24(9):2909-14. PubMed ID: 19225016
[TBL] [Abstract][Full Text] [Related]
18. The effects of angiotensin converting enzyme inhibitors on potassium homeostasis in dialysis patients with and without residual renal function.
Garthwaite E; Bhandari S
Artif Organs; 2009 Aug; 33(8):641-7. PubMed ID: 19624582
[TBL] [Abstract][Full Text] [Related]
19. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
20. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
